BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37691570)

  • 1. Hypothyroidism and subclinical hypothyroidism are associated with fatty pancreas (Non-Alcoholic Fatty Pancreas Disease).
    Bayyigit A; Gokden Y; Onol S; Ozek FZ; Saglam S; Adas M
    Diabetes Metab Res Rev; 2024 Feb; 40(2):e3720. PubMed ID: 37691570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between pancreas steatosis and metabolic syndrome: A systematic review and meta-analysis.
    Bi Y; Wang JL; Li ML; Zhou J; Sun XL
    Diabetes Metab Res Rev; 2019 Jul; 35(5):e3142. PubMed ID: 30767421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population.
    Zhou J; Li ML; Zhang DD; Lin HY; Dai XH; Sun XL; Li JT; Song LY; Peng H; Wen MM
    Pancreatology; 2016; 16(4):578-83. PubMed ID: 27050733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Assess Non Alcoholic Fatty Liver Disease in Patients with Clinical and Subclinical Hypothyroidism.
    R M; R M; S R; Ganga R
    J Assoc Physicians India; 2023 Jan; 71(1):1. PubMed ID: 37116028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical and clinical hypothyroidism and non-alcoholic fatty liver disease: a cross-sectional study of a random population sample aged 18 to 65 years.
    Ludwig U; Holzner D; Denzer C; Greinert A; Haenle MM; Oeztuerk S; Koenig W; Boehm BO; Mason RA; Kratzer W; Graeter T;
    BMC Endocr Disord; 2015 Aug; 15():41. PubMed ID: 26276551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Associations between metabolic syndrome, serum thyrotropin, and thyroid antibodies status in postmenopausal women, and the role of interleukin-6.
    Siemińska L; Wojciechowska C; Walczak K; Borowski A; Marek B; Nowak M; Kajdaniuk D; Foltyn W; Kos-Kudła B
    Endokrynol Pol; 2015; 66(5):394-403. PubMed ID: 26457493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Interrelation Between Hypothyroidism and Non-alcoholic Fatty Liver Disease, a Cross-sectional Study.
    Elshinshawy S; Elhaddad H; Abdel Alem S; Shaker O; Salam R; Yosry A; Elebrashy I
    J Clin Exp Hepatol; 2023; 13(4):638-648. PubMed ID: 37440948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic steatosis and iron overload increases cardiovascular risk in non-alcoholic fatty liver disease.
    Marti-Aguado D; Ten-Esteve A; Baracaldo-Silva CM; Crespo A; Coello E; Merino-Murgui V; Fernandez-Paton M; Alfaro-Cervello C; Sánchez-Martín A; Bauza M; Jimenez-Pastor A; Perez-Girbes A; Benlloch S; Pérez-Rojas J; Puglia V; Ferrández A; Aguilera V; Latorre M; Monton C; Escudero-García D; Bosch-Roig I; Alberich-Bayarri Á; Marti-Bonmati L
    Front Endocrinol (Lausanne); 2023; 14():1213441. PubMed ID: 37600695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between pancreas steatosis and the risk of metabolic syndrome and insulin resistance in Chinese adolescents with concurrent obesity and non-alcoholic fatty liver disease.
    Chiyanika C; Chan DFY; Hui SCN; So HK; Deng M; Yeung DKW; Nelson EAS; Chu WCW
    Pediatr Obes; 2020 Sep; 15(9):e12653. PubMed ID: 32351030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonalcoholic Fatty Pancreas Disease.
    Shah N; Rocha JP; Bhutiani N; Endashaw O
    Nutr Clin Pract; 2019 Oct; 34 Suppl 1():S49-S56. PubMed ID: 31535735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence and clinical implications of pancreatic fat accumulation identified during a medical check-up.
    Okada K; Watahiki T; Horie K; Takayama T; Aida Y; To K; Shida T; Ishige K; Nishiyama H; Shoda J; Suzuki H
    Medicine (Baltimore); 2021 Oct; 100(41):e27487. PubMed ID: 34731128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.
    Romana BS; Chela H; Dailey FE; Nassir F; Tahan V
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):547-554. PubMed ID: 29595117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance and central obesity determine hepatic steatosis and explain cardiovascular risk in steatotic liver disease.
    Semmler G; Balcar L; Wernly S; Völkerer A; Semmler L; Hauptmann L; Wernly B; Aigner E; Niederseer D; Datz C
    Front Endocrinol (Lausanne); 2023; 14():1244405. PubMed ID: 37842290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between non-alcoholic fatty pancreatic disease (NAFPD) and the metabolic syndrome: case-control retrospective study.
    Wu WC; Wang CY
    Cardiovasc Diabetol; 2013 May; 12():77. PubMed ID: 23688357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between novel MRI-estimated pancreatic fat and liver histology-determined steatosis and fibrosis in non-alcoholic fatty liver disease.
    Patel NS; Peterson MR; Brenner DA; Heba E; Sirlin C; Loomba R
    Aliment Pharmacol Ther; 2013 Mar; 37(6):630-9. PubMed ID: 23383649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid dysfunction and hepatic steatosis in overweight children and adolescents.
    Kaltenbach TE; Graeter T; Oeztuerk S; Holzner D; Kratzer W; Wabitsch M; Denzer C
    Pediatr Obes; 2017 Feb; 12(1):67-74. PubMed ID: 26877190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hepatic steatosis and fatty pancreas--2 targets of metabolic syndrom in children].
    Aleshina EI; Novikova VP; Gur'eva VA; Burnysheva IA; Usychenko EA
    Eksp Klin Gastroenterol; 2014; (8):16-20. PubMed ID: 25911907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and clinical characteristics of fatty pancreas in Yangzhou, China: A cross-sectional study.
    Wang D; Yu XP; Xiao WM; Jiao XP; Wu J; Teng DL; Wu KY; Zhang M; Zhu QT; Liu XN; Ding YB; Lu GT
    Pancreatology; 2018 Apr; 18(3):263-268. PubMed ID: 29477252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound.
    Petrović G; Bjelaković G; Benedeto-Stojanov D; Nagorni A; Brzački V; Marković-Živković B
    Vojnosanit Pregl; 2016 Oct; 73(10):910-20. PubMed ID: 29327896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.